Phase 1 Study to Compare CMAB807 Injection to Prolia® in Healthy Volunteers
Clinical trial NCT03925051 · COMPLETED
Trial details
- NCT number
- NCT03925051
- Sponsor
- Shanghai Biomabs Pharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-07-01
- Primary completion
- 2020-03-21
- Enrollment
- 132
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.